222 related articles for article (PubMed ID: 19770377)
1. New lesions detected by single nucleotide polymorphism array-based chromosomal analysis have important clinical impact in acute myeloid leukemia.
Tiu RV; Gondek LP; O'Keefe CL; Huh J; Sekeres MA; Elson P; McDevitt MA; Wang XF; Levis MJ; Karp JE; Advani AS; Maciejewski JP
J Clin Oncol; 2009 Nov; 27(31):5219-26. PubMed ID: 19770377
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML.
Gondek LP; Tiu R; O'Keefe CL; Sekeres MA; Theil KS; Maciejewski JP
Blood; 2008 Feb; 111(3):1534-42. PubMed ID: 17954704
[TBL] [Abstract][Full Text] [Related]
3. Adverse prognostic impact of abnormal lesions detected by genome-wide single nucleotide polymorphism array-based karyotyping analysis in acute myeloid leukemia with normal karyotype.
Yi JH; Huh J; Kim HJ; Kim SH; Kim HJ; Kim YK; Sohn SK; Moon JH; Kim SH; Kim KH; Won JH; Mun YC; Kim H; Park J; Jung CW; Kim DH
J Clin Oncol; 2011 Dec; 29(35):4702-8. PubMed ID: 22084373
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies.
Tiu RV; Gondek LP; O'Keefe CL; Elson P; Huh J; Mohamedali A; Kulasekararaj A; Advani AS; Paquette R; List AF; Sekeres MA; McDevitt MA; Mufti GJ; Maciejewski JP
Blood; 2011 Apr; 117(17):4552-60. PubMed ID: 21285439
[TBL] [Abstract][Full Text] [Related]
5. A genome-wide single-nucleotide polymorphism-array can improve the prognostic stratification of the core binding factor acute myeloid leukemia.
Huh J; Kim HJ; Jung CW; Kim HJ; Kim SH; Kim YK; Kim HJ; Shin MG; Moon JH; Sohn SK; Kim SH; Lee WS; Won JH; Mun YC; Kim H; Park J; Min WS; Kim DH;
Am J Hematol; 2012 Oct; 87(10):961-8. PubMed ID: 22886749
[TBL] [Abstract][Full Text] [Related]
6. Combining metaphase cytogenetics with single nucleotide polymorphism arrays can improve the diagnostic yield and identify prognosis more precisely in myelodysplastic syndromes.
Qin Y; Zhang H; Feng L; Wei H; Wu Y; Jiang C; Xu Z; Zhu H; Liu T
Ann Med; 2022 Dec; 54(1):2627-2636. PubMed ID: 36148999
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of genetic aberrations in secondary acute myeloid leukemia.
Milosevic JD; Puda A; Malcovati L; Berg T; Hofbauer M; Stukalov A; Klampfl T; Harutyunyan AS; Gisslinger H; Gisslinger B; Burjanivova T; Rumi E; Pietra D; Elena C; Vannucchi AM; Doubek M; Dvorakova D; Robesova B; Wieser R; Koller E; Suvajdzic N; Tomin D; Tosic N; Colinge J; Racil Z; Steurer M; Pavlovic S; Cazzola M; Kralovics R
Am J Hematol; 2012 Nov; 87(11):1010-6. PubMed ID: 22887079
[TBL] [Abstract][Full Text] [Related]
8. Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia.
Damm F; Heuser M; Morgan M; Yun H; Grosshennig A; Göhring G; Schlegelberger B; Döhner K; Ottmann O; Lübbert M; Heit W; Kanz L; Schlimok G; Raghavachar A; Fiedler W; Kirchner H; Döhner H; Heil G; Ganser A; Krauter J
J Clin Oncol; 2010 Feb; 28(4):578-85. PubMed ID: 20038731
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of single-nucleotide polymorphism array-based whole-genome analysis and uniparental disomy in myelodysplastic syndrome.
Ou Y; Yang Y; Yu H; Zhang X; Liu M; Wu Y
Int J Lab Hematol; 2021 Oct; 43(5):1062-1069. PubMed ID: 33650312
[TBL] [Abstract][Full Text] [Related]
10. Detection of cryptic chromosomal lesions including acquired segmental uniparental disomy in advanced and low-risk myelodysplastic syndromes.
Gondek LP; Haddad AS; O'Keefe CL; Tiu R; Wlodarski MW; Sekeres MA; Theil KS; Maciejewski JP
Exp Hematol; 2007 Nov; 35(11):1728-38. PubMed ID: 17920760
[TBL] [Abstract][Full Text] [Related]
11. Uniparental disomy may be associated with microsatellite instability in acute myeloid leukemia (AML) with a normal karyotype.
Serrano E; Carnicer MJ; Orantes V; Estivill C; Lasa A; Brunet S; Aventín AM; Sierra J; Nomdedéu JF
Leuk Lymphoma; 2008 Jun; 49(6):1178-83. PubMed ID: 18452069
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of acquired copy-neutral loss of heterozygosity in acute myeloid leukemia.
Gronseth CM; McElhone SE; Storer BE; Kroeger KA; Sandhu V; Fero ML; Appelbaum FR; Estey EH; Fang M
Cancer; 2015 Sep; 121(17):2900-8. PubMed ID: 26033747
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of previously cryptic copy number alterations and loss of heterozygosity in pediatric acute myeloid leukemia and myelodysplastic syndrome determined using combined array comparative genomic hybridization plus single-nucleotide polymorphism microarray analyses.
Koh KN; Lee JO; Seo EJ; Lee SW; Suh JK; Im HJ; Seo JJ
J Korean Med Sci; 2014 Jul; 29(7):926-33. PubMed ID: 25045224
[TBL] [Abstract][Full Text] [Related]
14. Single nucleotide polymorphism array-based karyotyping in acute myeloid leukemia or myelodysplastic syndrome with trisomy 8 as the sole chromosomal abnormality.
Hahm C; Mun YC; Seong CM; Han SH; Chung WS; Huh J
Acta Haematol; 2013; 129(3):154-8. PubMed ID: 23208021
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance of Fms-Like Tyrosine Kinase 3 Internal Tandem Duplication Mutation in Non-Transplant Adult Patients with Acute Myeloblastic Leukemia: A Systematic Review and Meta-Analysis.
Rinaldi I; Louisa M; Wiguna FI; Budiani E; Mahardhika JC; Hukmi K
Asian Pac J Cancer Prev; 2020 Oct; 21(10):2827-2836. PubMed ID: 33112537
[TBL] [Abstract][Full Text] [Related]
16. SNP array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in MDS/MPD-U and MPD.
Gondek LP; Dunbar AJ; Szpurka H; McDevitt MA; Maciejewski JP
PLoS One; 2007 Nov; 2(11):e1225. PubMed ID: 18030353
[TBL] [Abstract][Full Text] [Related]
17. Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome.
da Silva FB; Machado-Neto JA; Bertini VHLL; Velloso EDRP; Ratis CA; Calado RT; Simões BP; Rego EM; Traina F
J Clin Pathol; 2017 May; 70(5):435-442. PubMed ID: 27836923
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: results of the ALFA-0701 trial.
Renneville A; Abdelali RB; Chevret S; Nibourel O; Cheok M; Pautas C; Duléry R; Boyer T; Cayuela JM; Hayette S; Raffoux E; Farhat H; Boissel N; Terre C; Dombret H; Castaigne S; Preudhomme C
Oncotarget; 2014 Feb; 5(4):916-32. PubMed ID: 24659740
[TBL] [Abstract][Full Text] [Related]
19. Single-Nucleotide Polymorphism Array Technique Generating Valuable Risk-Stratification Information for Patients With Myelodysplastic Syndromes.
Xiao X; He X; Li Q; Zhang W; Zhu H; Yang W; Li Y; Geng L; Liu H; Li L; Wang H; Fu R; Zhao M; Chen Z; Shao Z
Front Oncol; 2020; 10():962. PubMed ID: 32733790
[No Abstract] [Full Text] [Related]
20. FISH and SNP-A karyotyping in myelodysplastic syndromes: improving cytogenetic detection of del(5q), monosomy 7, del(7q), trisomy 8 and del(20q).
Makishima H; Rataul M; Gondek LP; Huh J; Cook JR; Theil KS; Sekeres MA; Kuczkowski E; O'Keefe C; Maciejewski JP
Leuk Res; 2010 Apr; 34(4):447-53. PubMed ID: 19758696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
